RALEIGH, NC--(Marketwire - January 21, 2010) -
| Highlighted Links |
Macreport |
InoLife Technologies, Inc. through its InoVet, Ltd. subsidiary is involved in specialized veterinary research and treatment for companion animals.
Additionally, InoLife Technologies, Inc. has entered into a strategic partnership with InoHealth Products, Inc. InoHealth Products, Inc. has currently identified and is developing multi-faceted, human diagnostic and human DNA product lines to be marketed towards both professional medical and retail customers.
Safe Harbor Statement
This press release contains statements that may constitute "forward-looking
statements" within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, as amended by the Private Securities
Litigation Reform Act of 1995. Those statements include statements
regarding the intent, belief or current expectations of InoLife
Technologies, Inc. and members of its management as well as the assumptions
on which such statements are based. Prospective investors are cautioned
that any such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual results
may differ materially from those contemplated by such forward-looking
statements. Important factors currently known to management that could
cause actual results to differ materially from those in forward-statements
include fluctuation of operating results, the ability to compete
successfully, and the ability to complete before-mentioned transactions.
The company undertakes no obligation to update or revise forward-looking
statements to reflect changed assumptions, the occurrence of unanticipated
events or changes to future operating results.
